Monographie - Docetaxel

Ultimo aggiornamento :
03/05/2024

Docetaxel

Struttura chimica

Nome commerciale

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Adenex	Colombia
Asodocel	Argentina
Axogen	Chile
Bagotaxel	Chile
Bendadocel	Germania
Brecasta	Chile
Celtere	Perù
Daxotel	Chile, Colombia, Egitto, Malaysia
Doce NC	Germania
Docefrez	India, Stati Uniti d’America
Docekebir	Argentina
Docetax	Iran, Venezuela
Docetaxin	Germania
Docewin	Marocco
Dolectran	Argentina
Donataxel	Argentina, Ecuador, Perù
Doxel	Turchia, Venezuela
Doxetal	Argentina
Doxitax	Turchia
Oncodocel	Colombia, Perù
Onkotaxel	Austria, Colombia
Ribodocel	Germania
Santax	Turchia
Tadocel	Turchia
Taxceus	Gran Bretagna
Taxotan	Germania
Taxotere	Arabia Saudita, Argentina, Australia, Austria, Belgio, Canada, Chile, Colombia, Croazia, Danimarca, Ecuador, Egitto, Emirati Arabi Uniti, Finlandia, Francia, Germania, Giappone, Gran Bretagna, Grecia, Iran, Islanda, Italia, Lussemburgo, Malaysia, Marocco, Messico, Norvegia, Nuova Zelanda, Paesi Bassi, Polonia, Portogallo, Romania, Spagna, Stati Uniti d’America, Svezia, Svizzera, Tailandia, Tunisia, Turchia, Ungheria, Venezuela
Texot	Argentina
Tolnexa	Romania
Zenotere	India, Perù

Bibliografia : Docetaxel

	Tipo	Pubblicazione
140	Rivista	Pearson SD, Trissel LA. Leaching of diethylhexyl phthalate from polyvinyl chloride containers by selected drugs and formulation components. Am J Hosp Pharm 1993 ; 50: 1405-1409.
250	Rivista	Mazzo DJ, Nguyen-Huu JJ, Pagniez S, Denis P. Compatibility of docetaxel and paclitaxel in intravenous solutions with polyvinyl chloride infusion materials. Am J Health-Syst Pharm 1997 ; 54: 566-569.
251	Rivista	Trissel LA, Gilbert DL, Martinez JF. Compatibility of doxorubicin hydrochloride liposome injection with selected other drugs during simulated Y-site administration. Am J Health-Syst Pharm 1997 ; 54: 2708-2713.
1423	Rivista	Trissel LA, Martinez JF, Gilbert DL. Compatibility of gemcitabine hyrochloride with 107 selected drugs during simulated Y-site injection. J Am Pharm Assoc 1999 ; 39: 514-518.
1660	Rivista	Thiesen J, Krämer I. Physico-chemical stability of docetaxel premix solution and docetaxel infusion solutions in PVC bags and polyolefine containers. Pharm World Sci 1999 ; 21: 137-141.
1662	Rivista	Trissel LA, Saenz CA, Ingram DS, Ogundele AB. Compatibility screening of oxaliplatin during simulated Y-site administration with other drugs. J Oncol Pharm Practice 2002 ; 8: 33-37.
1754	Rivista	Trissel LA, Gilbert DL, Wolkin AC. Compatibility of docetaxel with selected drugs during simulated Y-site administration. Int J Pharm Compound 1999 ; 3: 241-244.
1940	Rivista	Xu QA, Trissel LA. Stability of palonosetron hydrochloride with paclitaxel and docetaxel during simulated Y-site administration. Am J Health-Syst Pharm 2004 ; 61: 1596-1598.
1953	Rivista	Trissel LA, Saenz CA, Ogundele AB, Ingram DS. Physical compatibility of pemetrexed disodium with other drugs during simulated Y-site administration. Am J Health-Syst Pharm 2004 ; 61: 2289-2293.
1982	Rivista	Trissel LA, Ogundele AB. Compatibility of anidulafungin with other drugs during simulated Y-site administration. Am J Health-Syst Pharm 2005 ; 62: 834-837.
2175	Rivista	Dalle M, Sautou-Miranda V, Balayssac D, Bourlon S, Bagel S, Chopineau J. Peut-on conditionner les solutions de docétaxel dans des poches en PVC ? J Pharm Clin 2006 ; 25, 3: 147-152.
2210	Rivista	Walker S.E, Charbonneau F, Law S. Stability of Docetaxel Solution after Dilution in Ethanol and Storage in Vials and after Dilution in Normal Saline and Storage in Bags. Can J Hosp Pharm 2007 ; 60, 4: 231-237.
2262	Rivista	Brammer MK, Chan P, Heatherly K, Trusley C, Kupiec TC, Trissel LA, Psathas PA, Gilmor T, Schaufelberger D. Compatibility of doripenem with other drugs during simulated Y-site administratioN Am J Health-Syst Pharm 2008 ; 65: 1261-1265.
2341	Poster	Bourlon S, Sautou-Miranda V, Dalle M. Release of di(2-ethylhexyl)phtalate from polyvinylchloride bags during docetaxel infusions Poster ESCP Stockholm May 2005
3130	Laboratorio	Docétaxel (Taxotere®) – Résumé des caractéristiques du produits Sanofi Avantis France 2009
3163	Rivista	Acott SR, Hart M. Physical and chemical stability of Taxotere 1-vial 20mg/mL infusion solution following refrigerated storage. EJHP 2010 ; 16, 5: 26-28.
3195	Rivista	MacLeod S, Sewell G. Physical and chemical stability of docetaxel infusions. EJHP 2011 ; 17, 2: 39-43.
3215	Rivista	Hart MC, Ahmed W. Taxotere 1-vial (docetaxel 20 mg/ml) physical and chemical stability over 28 days in infusion bags containing 0.9% saline solution and 5% glucose solution. EJOP 2011 ; 5,1: 24-27.
3277	Rivista	Yang Z, Cameron S, Paul H. Stability of Carboplatin, Paclitaxel, and Docetaxel with Acetyl-L-carnitine During Simulated Y-site Administration. Int J Pharm Compound 2012 ; 16, 1 : 82-85.
3804	Rivista	Lazzarini R, Salvadori S, Trapella C, Guerrini R, Marzola E, Pasini G, Dalpiaz A. Physicochemical stability of cabazitaxel and docetaxel solutions. EJHP 2014 ;22:150-155.
3937	Rivista	Park K.H, Chung D.J. Stability study of docetaxel solution (0.9% saline) using Non-PVC and PVC tubes for intravenous administration. Biomat Res 2015 ; 19, 2

Mentions Légales